Evidence map›Paper›PMID 38805413›Full record

ArticleACS applied bio materials2024

Fibril-Guided Three-Dimensional Assembly of Human Fibroblastic Reticular Cells.

Ketki Y Velankar, Wen Liu, Paul R Hartmeier, Samuel R Veleke, Gayathri Aparnasai Reddy, Benjamin Clegg, Ellen S Gawalt, Yong Fan, Wilson S Meng

Abstract read
In one paragraph

Article in ACS applied bio materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ketki Y VelankarGraduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh Pennsylvania 15282, United States.
Wen LiuAllegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh Pennsylvania 15212, United States.
Paul R HartmeierGraduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh Pennsylvania 15282, United States.
Samuel R VelekeGraduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh Pennsylvania 15282, United States.
Gayathri Aparnasai ReddyGraduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh Pennsylvania 15282, United States.
Benjamin CleggDepartment of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Ellen S GawaltDepartment of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Yong FanAllegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh Pennsylvania 15212, United States.
Wilson S MengGraduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh Pennsylvania 15282, United States.ORCID 0000-0003-2575-2260

Funding

Novel hematopoietic humanized mouse model to study CAR-T therapy-associated cytokine release syndromeR21OD034476 · OD · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI FAN, YONG · 2023 to 2024
$445k
DEVELOPMENT OF A REGULATORY T CELL MIMETIC FOR TOLERANCE INDUCTION IN SKIN TRANSPLANTATIONR21AI139828 · NIAID · DUQUESNE UNIVERSITY · PI MENG, WILSON S · 2019 to 2020
$378k
NIAID NIH HHS R21 AI139828NIH HHS R21 OD034476
6 · The paper itself

Abstract

Fibroblastic reticular cells (FRCs) are stromal cells (SCs) that can be isolated from lymph node (LN) biopsies. Studies have shown that these nonhematopoietic cells have the capacity to shape and regulate adaptive immunity and can become a form of personalized cell therapy. Successful translational efforts, however, require the cells to be formulated as injectable units, with their native architecture preserved. The intrinsic reticular organization of FRCs, however, is lost in the monolayer cultures. Organizing FRCs into three-dimensional (3D) clusters would recapitulate their structural and functional attributes. Herein, we report a scaffolding method based on the self-assembling peptide (SAP) EAKII biotinylated at the N-terminus (EAKbt). Cross-linking with avidin transformed the EAKbt fibrils into a dense network of coacervates. The combined forces of fibrillization and bioaffinity interactions in the cross-linked EAKbt likely drove the cells into a cohesive 3D reticula. This facile method of generating clustered FRCs (clFRCs) can be completed within 10 days. In vitro clFRCs attracted the infiltration of T cells and rendered an immunosuppressive milieu in the cocultures. These results demonstrate the potential of clFRCs as a method for stromal cell delivery.

Indexed as

Biocompatible MaterialsFibroblastsCells, CulturedHumansMaterials TestingParticle SizePeptidesStromal CellsBiocompatible MaterialsPeptides3D cell culturecell therapyinjectable scaffoldlymph nodelymph node stromal cellsself-assembling peptidespheroidsT cell tolerance

Identifiers

PMID38805413
PMCPMC11190984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.